Updated Jul 16, 2026
ARMEN GARO H has filed 8 SEC Form 4 filings across 1 company in the last 90 days.
Garo H. Armen is the founder and CEO of Agenus Inc, a clinical-stage biotechnology company focused on developing immunotherapies for cancer. He has played a significant role in advancing the company's pipeline of therapies and has extensive experience in the biotechnology sector.
| Role | Insider |
|---|---|
| Notability | 50/100 |
| Links | Wikipedia |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-14 | AGEN | AGENUS INC | A — Grant or award | 4.9K | $3.35 | $16K |
| 2026-06-30 | AGEN | AGENUS INC | A — Grant or award | 5.4K | $3.03 | $16K |
| 2026-06-16 | AGEN | AGENUS INC | A — Grant or award | 4.9K | $3.30 | $16K |
| 2026-06-02 | AGEN | AGENUS INC | A — Grant or award | 4.6K | $3.50 | $16K |
| 2026-05-19 | AGEN | AGENUS INC | A — Grant or award | 4.5K | $3.58 | $16K |
| 2026-05-05 | AGEN | AGENUS INC | A — Grant or award | 4.2K | $3.84 | $16K |
| 2026-04-21 | AGEN | AGENUS INC | A — Grant or award | 3.4K | $4.79 | $16K |
| 2026-04-06 | AGEN | AGENUS INC | A — Grant or award | 4.6K | $3.33 | $15K |
| 2026-03-24 | AGEN | AGENUS INC | A — Grant or award | 4.0K | $3.71 | $15K |
| 2026-03-09 | AGEN | AGENUS INC | A — Grant or award | 5.0K | $2.96 | $15K |
| 2026-02-24 | AGEN | AGENUS INC | A — Grant or award | 4.8K | $3.06 | $15K |
| 2026-02-09 | AGEN | AGENUS INC | A — Grant or award | 5.0K | $2.94 | $15K |
| 2026-01-26 | AGEN | AGENUS INC | A — Grant or award | 4.6K | $3.24 | $15K |
| 2026-01-12 | AGEN | AGENUS INC | A — Grant or award | 3.8K | $3.91 | $15K |
| 2025-12-29 | AGEN | AGENUS INC | A — Grant or award | 4.9K | $3.31 | $16K |
| 2025-12-01 | AGEN | AGENUS INC | A — Grant or award | 3.6K | $4.56 | $16K |
| 2025-11-17 | AGEN | AGENUS INC | A — Grant or award | 3.8K | $4.34 | $16K |
| 2025-11-05 | AGEN | AGENUS INC | A — Grant or award | 4.1K | $3.97 | $16K |
| 2025-10-21 | AGEN | AGENUS INC | A — Grant or award | 4.2K | $3.88 | $16K |
| 2025-10-03 | AGEN | AGENUS INC | A — Grant or award | 4.0K | $4.14 | $16K |
Garo H. Armen is the founder and CEO of Agenus Inc, a clinical-stage biotechnology company focused on developing immunotherapies for cancer. He has played a significant role in advancing the company's pipeline of therapies and has extensive experience in the biotechnology sector.…
8 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live ARMEN GARO H profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.